🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 4

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 4 of 9
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jun 6, 2025 at 3:15 PM#16

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

4 2kevin_tulsa, Dr.PainCLE, mike_mealprep and 1 other
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Jun 6, 2025 at 6:33 PM#17

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Jun 6, 2025 at 7:33 PM
5 3TinaHashiRN, robert_kc, dan_philly and 2 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Jun 6, 2025 at 9:51 PM#18
hans_munich said:
It helps to ask what evidence would change your mind before you look at any.

Pushing back on hans_munich here. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

Last edited: Jun 7, 2025 at 3:51 AM
6 4BrianDallas92, labquiet_amy, emily_PDX and 3 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Jun 7, 2025 at 1:09 AM#19
hans_munich said:
It helps to ask what evidence would change your mind before you look at any.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Ask again with the specifics and you will get a better answer than this one.

7 5SandraNC_45, Dr.EndoIndy, tom_AK and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 7, 2025 at 4:27 AM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. No action needed from anybody.

Last edited: Jun 7, 2025 at 8:27 AM
29 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 26 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register